Jaime Landman MD, Director of Minimally Invasive Urology at Columbia Medical Center discusses Cytoreductive Nephrectomy, the cutting edge of kidney cancer management for patients whose disease is not contained to the kidney.

Summary:
1. Cytoreductive nephrectomy is a laparoscopic technique for the management of kidney cancer when the disease is no longer contained within the kidney.

2. When possible, it is preferable to open surgery because it is less invasive and has a much shorter recovery time, allowing the patient to commence adjunctive therapy as quickly as possible and improving quality of life.

References and Resources
Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J.
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. Polcari AJ, Gorbonos A, Milner JE, Flanigan RC.
The role of cytoreductive nephrectomy in the era of molecular targeted therapy. Int J Urol. 2009 Feb 4.

Sponsored by The Doctor’s Channel